tiprankstipranks
China Feihe Limited (HK:6186)
:6186
Hong Kong Market

China Feihe Limited (6186) AI Stock Analysis

14 Followers

Top Page

HK:6186

China Feihe Limited

(6186)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
HK$4.00
▼(-0.74% Downside)
Action:ReiteratedDate:07/08/25
The overall score of 55 reflects strong financial health, tempered by significant technical weaknesses and modest valuation. The stock's technical analysis indicates bearish momentum, with the price below major moving averages and an oversold RSI. Despite a solid equity base and positive cash flow, declining net profit margins and inconsistent revenue growth raise concerns about future performance.
Positive Factors
High gross margins
Gross margins consistently above 60% indicate durable production efficiency and pricing power in infant formula. This margin structure provides a long-term buffer against raw‑milk cost swings, supports reinvestment in R&D and branding, and helps sustain operating profitability even with volume volatility.
Negative Factors
Net margin compression
A near halving of net margins over four years signals structural pressure on profitability, from cost increases, pricing pressure or higher operating expenses. Persisting margin erosion reduces retained earnings, limits reinvestment capacity and weakens long‑term earnings power even if gross margins remain high.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
Gross margins consistently above 60% indicate durable production efficiency and pricing power in infant formula. This margin structure provides a long-term buffer against raw‑milk cost swings, supports reinvestment in R&D and branding, and helps sustain operating profitability even with volume volatility.
Read all positive factors

China Feihe Limited (6186) vs. iShares MSCI Hong Kong ETF (EWH)

China Feihe Limited Business Overview & Revenue Model

Company Description
China Feihe Limited, an investment holding company, produces and sells infant milk formula products in Mainland China and the United States. The company offers a range of raw milk, adult milk powders, liquid milk products and health care products,...
How the Company Makes Money
China Feihe Limited generates revenue primarily through the sale of its infant formula products, which are marketed under several well-known brands. The company operates a multi-channel distribution strategy that includes online platforms, retail ...

China Feihe Limited Financial Statement Overview

Summary
China Feihe Limited demonstrates robust financial health with strong gross margins and a stable equity base. However, challenges with declining net profit margins, inconsistent revenue growth, and reduced return on equity indicate areas for improvement. Cash flow generation remains positive, ensuring the company can meet its financial obligations while supporting growth opportunities.
Income Statement
65
Positive
Balance Sheet
72
Positive
Cash Flow
70
Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue19.80B20.75B19.53B21.31B22.78B18.59B
Gross Profit12.55B13.76B12.66B13.95B16.01B13.48B
EBITDA4.50B6.24B5.51B6.25B8.41B7.13B
Net Income2.70B3.57B3.39B4.94B6.87B7.44B
Balance Sheet
Total Assets33.90B35.73B36.19B35.52B31.48B28.32B
Cash, Cash Equivalents and Short-Term Investments16.86B19.00B19.15B19.11B17.18B16.41B
Total Debt845.01M1.08B1.64B1.50B1.11B1.42B
Total Liabilities6.75B8.32B9.86B10.04B9.08B9.14B
Stockholders Equity25.61B25.93B24.94B23.99B20.92B17.75B
Cash Flow
Free Cash Flow1.28B2.68B2.61B3.80B4.80B6.89B
Operating Cash Flow2.69B4.18B4.15B6.28B6.81B7.75B
Investing Cash Flow-1.04B-1.32B386.70M-4.80B-2.44B-3.79B
Financing Cash Flow-3.22B-3.03B-2.71B-1.98B-4.25B-2.54B

China Feihe Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.03
Price Trends
50DMA
3.84
Negative
100DMA
3.99
Negative
200DMA
4.22
Negative
Market Momentum
MACD
-0.10
Positive
RSI
30.39
Neutral
STOCH
13.65
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6186, the sentiment is Negative. The current price of 4.03 is above the 20-day moving average (MA) of 3.76, above the 50-day MA of 3.84, and below the 200-day MA of 4.22, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 30.39 is Neutral, neither overbought nor oversold. The STOCH value of 13.65 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6186.

China Feihe Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$136.39B9.1114.19%6.66%5.98%62.13%
67
Neutral
HK$56.30B8.3723.50%3.26%2.03%1.43%
65
Neutral
HK$75.30B13.6124.09%5.46%-1.68%22.06%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
56
Neutral
HK$67.94B3.79%3.62%-7.36%-107.25%
55
Neutral
HK$31.70B8.887.69%6.70%-0.64%-24.62%
48
Neutral
HK$3.24B18.392.84%2.90%0.52%99.51%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6186
China Feihe Limited
3.50
-1.99
-36.25%
HK:0151
Want Want China Holdings
4.77
0.06
1.23%
HK:0288
WH Group
10.63
4.67
78.39%
HK:2319
China Mengniu Dairy Co
17.55
-0.75
-4.10%
HK:0322
Tingyi (Cayman Islands) Holding
13.36
1.14
9.31%
HK:1717
Ausnutria Dairy Corp. Ltd.
1.82
-0.13
-6.67%

China Feihe Limited Corporate Events

China Feihe Deploys RMB600 Million of Idle Cash Into CITIC Bank Wealth Product
Dec 28, 2025
China Feihe has further deployed its surplus cash into low-risk treasury investments, with its wholly owned subsidiary Feihe HLJ subscribing on 26 December 2025 to a RMB600 million closed-ended fixed-income wealth management product from CITIC Ban...
China Feihe Channels RMB300 Million of Idle Cash Into New SPD Bank Wealth Product
Dec 28, 2025
China Feihe Limited has deployed RMB300 million of idle funds into a new wealth management product from SPD Bank, subscribing on 25 December 2025 to the Shangxin Xinyue Fengli Assembled Fund Trust Scheme EL2001 Phase 191, a non-principal-guarantee...
China Feihe Invests RMB300 Million in CITIC Bank Wealth Management Product
Dec 19, 2025
China Feihe Limited has disclosed that its wholly owned subsidiary Feihe HLJ has subscribed to a RMB300 million closed-ended wealth management product offered by CITIC Bank, using idle funds to earn an expected annual return of 2.40%–2.90% o...
China Feihe Limited Invests in CITIC Bank Financial Product to Boost Capital Gains
Dec 16, 2025
China Feihe Limited has announced that its wholly-owned subsidiary, Feihe HLJ Sales, has subscribed to a wealth management financial product offered by CITIC Bank, using RMB700 million of its idle funds. This strategic move aims to enhance the com...
China Feihe Limited Enhances Capital Gains with SPD Bank Subscription
Dec 8, 2025
China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products offered by SPD Bank using RMB300 million of idle funds. This strategic move aims to enhance the company’s capital gains while mai...
China Feihe Limited Enhances Capital Gains Through Strategic Financial Product Subscription
Nov 26, 2025
China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products offered by SPD Bank, utilizing RMB300 million of its idle funds. This strategic move aims to enhance the company’s capital gains ...
China Feihe Expands Agricultural Procurement with NL47 Agreement
Nov 5, 2025
China Feihe Limited has announced additional details regarding its NL47 Procurement Framework Agreement, which outlines the procurement of agricultural products at market prices determined through independent supplier quotes or mutual agreement. T...
China Feihe Limited Invests RMB500 Million in SPD Bank Financial Products
Nov 5, 2025
China Feihe Limited announced that its wholly-owned subsidiary, Feihe HLJ, has subscribed to financial products offered by SPD Bank, amounting to RMB500 million. This move is part of the company’s strategy to utilize idle funds effectively, ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 08, 2025